# Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis

> **NCT01857284** · PHASE3 · COMPLETED · sponsor: **Beijing Friendship Hospital** · enrollment: 216 (actual)

## Conditions studied

- Primary Biliary Cirrhosis

## Interventions

- **DRUG:** Tauroursodeoxycholic Acid Capsules
- **DRUG:** Ursodeoxycholic Acid Capsules

## Key facts

- **NCT ID:** NCT01857284
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2013-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01857284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01857284, "Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01857284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*